News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Insider Information

Epigenomics AG issues mandatory convertible bond in the amount of up to EUR 5.5 million

Epigenomics AG / Key word(s): Issue of Debt/BondEpigenomics AG issues mandatory convertible bond in the amount of up to EUR 5.5 million 07-Jan-2021 / 09:36 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible […]

Read more

Epigenomics AG: Capital reduction and further authorization to issue convertible bonds with backstop investor planned

Epigenomics AG / Key word(s): Corporate Action/AGM/EGMEpigenomics AG: Capital reduction and further authorization to issue convertible bonds with backstop investor planned 03-Nov-2020 / 11:48 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for […]

Read more

Epigenomics AG: U.S. Centers for Medicare & Medicaid Services publish negative proposed NCD for Epi proColon

Epigenomics AG / Key word(s): MiscellaneousEpigenomics AG: U.S. Centers for Medicare & Medicaid Services publish negative proposed NCD for Epi proColon 17-Oct-2020 / 00:03 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for […]

Read more

Epigenomics AG successfully completes capital increase

Epigenomics AG / Key word(s): Capital IncreaseEpigenomics AG successfully completes capital increase 31-March-2020 / 09:02 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. NOT FOR PUBLICATION, DISTRIBUTION […]

Read more

Epigenomics AG decides to increase share capital by way of private placement

Epigenomics AG / Key word(s): Capital Increase/Corporate ActionEpigenomics AG decides to increase share capital by way of private placement 30-March-2020 / 19:53 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content […]

Read more

Centers for Medicare & Medicaid Services open NCD review process for Epi proColon

Epigenomics AG / Key word(s): MiscellaneousCenters for Medicare & Medicaid Services open NCD review process for Epi proColon 28-Feb-2020 / 23:02 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of […]

Read more